Jerusalem, Israel

Schmuel Ben-Sasson


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Schmuel Ben-Sasson

Introduction

Schmuel Ben-Sasson is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of two patents to his name, Ben-Sasson has focused on developing biologically active polymeric compounds and aromatic oligomeric compounds.

Latest Patents

Ben-Sasson's latest patents include "Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical" and "Aromatic oligomeric compounds useful as mimics of bioactive." The first patent describes a biologically active polymeric compound that features an alkylaryl or heteroalkylaryl backbone. This compound is capable of forming a linear backbone with a helical secondary structure, which is crucial for its biological activity. The second patent relates to aromatic oligomeric compounds that are useful in treating various disorders, including cardiovascular and gastrointestinal issues. These compounds are designed to bind DNA and are included in pharmaceutical compositions for effective treatment.

Career Highlights

Schmuel Ben-Sasson has worked with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of new treatments for complex health issues.

Collaborations

Throughout his career, Ben-Sasson has collaborated with notable colleagues, including John R. Regan and Michael N. Chang. These collaborations have likely enhanced the scope and impact of his research and inventions.

Conclusion

Schmuel Ben-Sasson is a distinguished inventor whose work in the field of pharmaceuticals has led to significant advancements. His innovative patents reflect his commitment to improving health outcomes through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…